Glaxosmithkline Share News (GSK)

UK dividends calendar - next 7 days

GSK, Haleon, Sanofi slump amid Zantac litigation woes

(Sharecast News) - Shares in GlaxoSmithKline, Haleon and Sanofi tumbled on Thursday amid concerns about legal proceedings related to Glaxo's former blockbuster heartburn drug Zantac.

LONDON MARKET MIDDAY: Stocks down; Haleon and GSK hit by Zantac worry

(Alliance News) - Stock prices in London were mostly lower at midday on Thursday as a rally fuelled by cooling US inflation lost steam, while Walt Disney shares surged in New York after posting huge subscriber growth.

Haleon not a party to U.S. litigation focused on Zantac - spokesperson

LONDON, Aug 11 (Reuters) - Haleon - GSK's recently spun off consumer health unit - is not a party to the U.S. litigation focused on the heartburn medicine Zantac, a spokesperson told Reuters on Thursday.

LONDON MARKET CLOSE: Cooler US CPI provides shot in the arm for stocks

(Alliance News) - Stocks in London were buoyed on Wednesday by softening US inflation, raising hopes that the Federal Reserve will be less aggressive in its tightening when it meets next month.

LONDON BROKER RATINGS: JPMorgan raises L&G but cuts M&G and Phoenix

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Climate change puts Lyme disease in focus for France's Valneva after COVID blow

LONDON, Aug 8 (Reuters) - With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.

LONDON BRIEFING: Taylor Wimpey says UK housing market remains strong

(Alliance News) - Housebuilder Taylor Wimpey on Wednesday reported a rise in interim profit as it trimmed expenses.

GSK's Viiv in deal to allow generic of HIV prevention drug

(Alliance News) - A deal has been reached to allow for distribution of a low-cost generic version of a long-term preventative treatment against HIV in low-income countries where most of the world's infections occur, Unitaid and the Medicines Patent Pool announced Thursday.

Cheap copies of GSK's HIV prevention drug could be ready in 2026

LONDON, July 28 (Reuters) - British drugmaker GSK has struck a deal to allow low-cost generic versions of its long-acting HIV preventive medicine to be used in the developing world, including sub-Saharan Africa where the virus remains a leading cause of death.

Cheap copies of GSK's HIV prevention drug could be ready in 2026

LONDON, July 28 (Reuters) - British drugmaker GSK has struck a deal to allow low-cost generic versions of its long-acting HIV preventive medicine to be used in the developing world, including sub-Saharan Africa where the virus remains a leading cause of death.

IN BRIEF: GSK to supply 85 million doses of Adjupanrix vaccine to EU

GSK PLC - London-based pharmaceutical firm - Signs a framework contract with the European Commission's Health Emergency Preparedness & Response Authority. Says contract is for the reservation of future production and supply of 85 million doses of its influenza vaccine Adjupanrix. Does not disclose the financial details of the contract.

LONDON BROKER RATINGS: Bernstein ups Reckitt; Mitchells & Butlers cut

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Sanofi lifts profit outlook as Dupixent sales surge 43%

July 28 (Reuters) - French healthcare group Sanofi lifted its full-year earnings outlook on continued forecast-beating sales growth for its bestselling drug Dupixent.

TOP NEWS: GSK quarterly revenue drops as Haleon's interim revenue up

(Alliance News) - Pharmaceutical firm GSK PLC on Wednesday reported a fall in quarterly profit and revenue while its consumer health spin-out Haleon PLC touted an interim revenue growth.